Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation

作者: Gwen E. Dressing , Carol A. Lange

DOI: 10.1016/J.STEROIDS.2008.12.001

关键词: Signal transductionProgesterone receptorCell growthCyclinCell cycleCyclin-dependent kinaseCancerCancer researchBiologyBreast disease

摘要: Multiple laboratories have investigated progesterone receptor (PR) involvement in breast cancer cell cycle progression. There is now a growing body of evidence demonstrating complex interactions between PR and regulatory proteins. Here we review the current literature linking to control discuss gaps knowledge. A more complete understanding relationships molecules may reveal additional avenues for prevention treatment steroid positive cancers.

参考文章(40)
Carol A. Lange, Jennifer K. Richer, Kathryn B. Horwitz, HYPOTHESIS : PROGESTERONE PRIMES BREAST CANCER CELLS FOR CROSS-TALK WITH PROLIFERATIVE OR ANTIPROLIFERATIVE SIGNALS Molecular Endocrinology. ,vol. 13, pp. 829- 836 ,(1999) , 10.1210/MEND.13.6.0290
Amy Jo Galliher-Beckley, Jason Grant Williams, Jennifer Brady Collins, John Anthony Cidlowski, Glycogen Synthase Kinase 3β-Mediated Serine Phosphorylation of the Human Glucocorticoid Receptor Redirects Gene Expression Profiles Molecular and Cellular Biology. ,vol. 28, pp. 7309- 7322 ,(2008) , 10.1128/MCB.00808-08
Ramesh Narayanan, Dean P. Edwards, Nancy L. Weigel, Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Molecular and Cellular Biology. ,vol. 25, pp. 2885- 2898 ,(2005) , 10.1128/MCB.25.8.2885-2898.2005
Steve D. Groshong, Gareth I. Owen, Bryn Grimison, Irene E. Schauer, Maria C. Todd, Thomas A. Langan, Robert A. Sclafani, Carol A. Lange, Kathryn B. Horwitz, Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1 Molecular Endocrinology. ,vol. 11, pp. 1593- 1607 ,(1997) , 10.1210/MEND.11.11.0006
C. J. Burd, C. E. Petre, H. Moghadam, E. M. Wilson, K. E. Knudsen, Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression Molecular Endocrinology. ,vol. 19, pp. 607- 620 ,(2005) , 10.1210/ME.2004-0266
Christin E. Petre-Draviam, Craig J. Burd, Thomas W. Marshall, Karen E. Knudsen, Stephen L. Cook, Yelena B. Wetherill, Specificity of cyclin D1 for androgen receptor regulation. Cancer Research. ,vol. 63, pp. 4903- 4913 ,(2003)
R. M.L. Zwijsen, R. S. Buckle, E. M. Hijmans, C. J.M. Loomans, R. Bernards, Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1 Genes & Development. ,vol. 12, pp. 3488- 3498 ,(1998) , 10.1101/GAD.12.22.3488
Ramesh Narayanan, Abayomi A. Adigun, Dean P. Edwards, Nancy L. Weigel, Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Molecular and Cellular Biology. ,vol. 25, pp. 264- 277 ,(2005) , 10.1128/MCB.25.1.264-277.2005
Khawla Al-Kuraya, Peter Schraml, Joachim Torhorst, Coya Tapia, Boriana Zaharieva, Hedvika Novotny, Hanspeter Spichtin, Robert Maurer, Martina Mirlacher, Ossi Köchli, Markus Zuber, Holger Dieterich, Friedrich Mross, Kim Wilber, Ronald Simon, Guido Sauter, Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Research. ,vol. 64, pp. 8534- 8540 ,(2004) , 10.1158/0008-5472.CAN-04-1945